Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab
Hyung‐Don Kim, Sun Jin Sym, Hong Jae Chon, Moonho Kim, Jung Hun Kang, Baek‐Yeol Ryoo, Choong‐kun Lee, Joo-Hyun Hong, Hyewon Ryu, Woo Kyun Bae, Hyeyeong Kim, Hyunho Kim, Jin Won Kim, Tae‐Yong Kim, Changhoon Yoo
Topics & Concepts
LenvatinibAtezolizumabBevacizumabHepatocellular carcinomaMedicineOncologyInternal medicineFirst line treatmentCancerChemotherapySorafenibNivolumabImmunotherapyHepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathologyHepatitis B Virus Studies